Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Emcure Pharmaceuticals Ltd.
NSE: EMCURE
|
BSE: 544210
|
ISIN: INE168P01015
|
Industry: Pharmaceuticals
|
Mid-range Performer
1364.5000
-28.00
(
-2.01
%)
NSE
Dec 31, 2025
15:31 PM
53.49% Gain from 52W Low
Volume:
78,231
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Emcure Pharmaceuticals Ltd.
02 Jul 2024
1364.50
-2.01%
IPO Note Emcure Pharmaceuticals Ltd.
IPO Note:
Emcure Pharmaceuticals Ltd.
by
Ashika Research
Ashika Research
Number of FII/FPI investors increased from 84 to 102 in Sep 2025 qtr.
More from Emcure Pharmaceuticals Ltd.
Recommended
Market closes higher amid strong buying in steel stocks
Trendlyne Marketwatch |
31 Dec 2025, 04:01PM
2025 turns selective on returns: Themes outperform while headline indices stall
The Baseline |
31 Dec 2025, 03:05PM
IPO activity is high on listings, but low on subscriptions
|
29 Dec 2025